Insufficient scRNA-seq data for expression of ACOT2 at single-cell level.
Insufficient scRNA-seq data for expression of ACOT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2604.87 | 226 / 226 | 100% | 34.97 | 405 / 406 |
kidney | 100% | 1694.91 | 89 / 89 | 99% | 24.89 | 893 / 901 |
breast | 100% | 2340.08 | 458 / 459 | 99% | 32.42 | 1109 / 1118 |
thymus | 99% | 890.53 | 647 / 653 | 100% | 21.61 | 603 / 605 |
intestine | 100% | 1872.62 | 964 / 966 | 98% | 21.57 | 519 / 527 |
prostate | 99% | 1044.31 | 242 / 245 | 99% | 21.10 | 495 / 502 |
skin | 98% | 950.45 | 1775 / 1809 | 99% | 22.16 | 468 / 472 |
bladder | 100% | 1643.95 | 21 / 21 | 97% | 18.65 | 490 / 504 |
adrenal gland | 100% | 2235.05 | 258 / 258 | 97% | 16.09 | 223 / 230 |
stomach | 98% | 1088.22 | 351 / 359 | 99% | 21.42 | 283 / 286 |
uterus | 100% | 1521.77 | 170 / 170 | 96% | 17.55 | 442 / 459 |
lung | 96% | 1016.80 | 557 / 578 | 98% | 20.02 | 1133 / 1155 |
ovary | 96% | 690.90 | 172 / 180 | 98% | 25.36 | 423 / 430 |
esophagus | 95% | 1811.64 | 1379 / 1445 | 98% | 17.56 | 179 / 183 |
brain | 89% | 576.78 | 2361 / 2642 | 96% | 18.51 | 674 / 705 |
pancreas | 80% | 388.65 | 264 / 328 | 99% | 19.36 | 177 / 178 |
adipose | 100% | 2655.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 28.00 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.82 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.18 | 1 / 1 |
muscle | 100% | 2389.19 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1427.02 | 1326 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 660.60 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 94% | 2262.12 | 811 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 26% | 243.04 | 237 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000038 | Biological process | very long-chain fatty acid metabolic process |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0047617 | Molecular function | fatty acyl-CoA hydrolase activity |
GO_0005515 | Molecular function | protein binding |
GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
Gene name | ACOT2 |
Protein name | Acyl-CoA thioesterase 2 Acyl-coenzyme A thioesterase 2, mitochondrial (Acyl-CoA thioesterase 2) (EC 3.1.2.2) (Acyl-coenzyme A thioester hydrolase 2a) (CTE-Ia) (Long-chain acyl-CoA thioesterase 2) (ZAP128) |
Synonyms | PTE2A PTE2 |
Description | FUNCTION: Catalyzes the hydrolysis of acyl-CoAs into free fatty acids and coenzyme A (CoASH), regulating their respective intracellular levels . Displays higher activity toward long chain acyl CoAs (C14-C20) . The enzyme is involved in enhancing the hepatic fatty acid oxidation in mitochondria (By similarity). . |
Accessions | A0A087WT95 P49753 F6VI00 ENST00000538782.2 ENST00000613168.1 ENST00000238651.10 [P49753-1] |